Your search returned 3 results.

Results
	1.	Erlotinib is a well-tolerated alternate treatment for non-small cell lung cancer in cases of gefitinib-induced hepatotoxicity. [electronic resource] by Yonesaka, Kimio Suzumura, Tomohiro Tsukuda, Hiroshi Hasegawa, Yoshikazu Ozaki, Tomohiro Sugiura, Takamune Fukuoka, Masahiro Producer: 20141111 In: Anticancer research vol. 34 Availability: No items available. Save to lists Add to cart (remove)
	2.	Spontaneous pneumothorax due to bronchopleural fistula following reirradiation for locoregionally recurrent squamous cell lung cancer. [electronic resource] by Ota, Takayo Suzumura, Tomohiro Sugiura, Takamune Hasegawa, Yoshikazu Yonesaka, Kimio Makihara, Masaru Tsukuda, Hiroshi Tada, Takuhito Fukuoka, Masahiro Producer: 20160518 In: Clinical case reports vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG0401). [electronic resource] by Kaneda, Hiroyasu Okamoto, Isamu Hayashi, Hidetoshi Yoshioka, Hiroshige Miyazaki, Masaki Kudoh, Shinzoh Kimura, Tatsuo Sugiura, Takamune Sawa, Toshiyuki Takeda, Koji Iwamoto, Yasuo Satouchi, Miyako Akita, Kenji Saito, Hiroshi Goto, Isao Shibata, Kazuhiko Fukuoka, Masahiro Nakagawa, Kazuhiko Producer: 20100316 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)